Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?

Cancer Cytopathology

Volumn 121, Issue 3, 2013, Pages 116-119

  Faquin, William C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

CLASSIFIER; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FALSE NEGATIVE RESULT; FAMILY HISTORY; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; LYMPHADENOPATHY; MEDICAL DECISION MAKING; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID TUMOR; THYROIDECTOMY; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 84876260213     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21277     Document Type: Review

References (22)

1. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer (Cancer Cytopathol). 2007;111:508-516. (Pubitemid 350304903)
2. Castro MB, Gharib H. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract. 2003;9:128-136.
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer; Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
4. Werga P, Wallin G, Skoog L, Hamberger B. Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg. 2000;24:907-912. (Pubitemid 30461211)
5. Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg. 2008;32:1247-1252.
6. Li H, Robinson KA, Anton B, Sadhanha IJ, Ladenson PW. Costeffectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2011;96:E1719-E1726.
7. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm:" a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26:41-44. (Pubitemid 34037526)
8. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer (Cancer Cytopathology). 2007;111:306-315.
9. Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 2000;10:709-712.
10. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705-715.
11. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.
12. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21:S37-S43. (Pubitemid 351592770)
13. Ohori NP, Nikiforova MN, Schoedel KE, et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer (Cancer Cytopathol). 2010;118:17-23.
14. Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab. 2010;95:5296-5304.
15. Haugen BR, Baloch Z, Chudova D, et al. Development of a novel molecular classifier to accurately identify benign thyroid nodules in patients with indeterminate FNA cytology. Paper presented at: 14th International Thyroid Congress; September 11-16, 2010; Paris France. Abstract LB-03.
16. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-665.
17. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes. New York: Springer; 2010.
18. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration. Cancer (Cancer Cytopathol). 2009;117:195-202.
19. Krane JF, VanderLaan PA, Faquin WC, Renshaw A. The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in the Bethesda System for thyroid cytopathology. Cancer (Cancer Cytopathol). 2012;120:11-116.
20. Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and followup according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38:731-739.
21. Heller M, Zanocco K, Sydowicz S, Elaraj D, Nayar R, Sturgeon C. Cost-effective analysis of repeat fine-needle aspiration for thyroid biopsies read as atypia of undetermined significance. Surgery. 2012;152:423-430.
22. Nagarkatti SS, Faquin WC, Lubitz CC, et al. Management of nodules with atypical cytology on fine-needle aspiration biopsy [published online ahead of print September 1, 2012]. Ann Surg Oncol. 2012.